Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Receivables - Other: 2009-2019

Historic Receivables - Other for Ironwood Pharmaceuticals (IRWD) over the last 11 years, with Dec 2019 value amounting to $106.0 million.

  • Ironwood Pharmaceuticals' Receivables - Other rose 5.88% to $73.4 million in Q1 2020 from the same period last year, while for Mar 2020 it was $73.4 million, marking a year-over-year increase of 5.88%. This contributed to the annual value of $106.0 million for FY2019, which is 76.73% up from last year.
  • According to the latest figures from FY2019, Ironwood Pharmaceuticals' Receivables - Other is $106.0 million, which was up 76.73% from $60.0 million recorded in FY2018.
  • Ironwood Pharmaceuticals' Receivables - Other's 5-year high stood at $106.0 million during FY2019, with a 5-year trough of $51.6 million in FY2015.
  • Its 3-year average for Receivables - Other is $81.6 million, with a median of $79.0 million in 2017.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Receivables - Other soared by 99.91% in 2015 and then declined by 24.07% in 2018.
  • Ironwood Pharmaceuticals' Receivables - Other (Yearly) stood at $51.6 million in 2015, then rose by 23.80% to $63.9 million in 2016, then grew by 23.54% to $79.0 million in 2017, then declined by 24.07% to $60.0 million in 2018, then soared by 76.73% to $106.0 million in 2019.